摩通:降舜宇(2382.HK)评级至“中性” 目标价升至125港元
摩通发表报告指,舜宇(02382.HK)股价今年至今累升超过82%,表现跑赢大市,相信现价已反映其市占率上升及毛利率复苏,因此将其评级由“增持”降至“中性”。
报告补充,自从舜宇将业务重心放在高端手机摄像模组(CCM)方面後,华为智能手机的不确定性和不利的高端相机模组设计更改应引起市场对竞争的担忧,从而限制舜宇的相机模组毛利率的增长,且会抑制股份被重估的机会。
不过,该行上调舜宇2019及2020年销售预测10%及17%,盈利预测上调11%及4%,以反映第三季表现强劲及10月出货量,目标价因而由110港元上调至125港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.